10. Segment and Geographic Information
|9 Months Ended|
Dec. 31, 2019
|Segment Reporting [Abstract]|
|Segment and Geographic Information||
The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers. Additionally, the Company provides technical services to Invekra.
The following table presents the Company’s disaggregated product revenues by geographic region:
The Company’s service revenues amounted to $297,000 and $235,000 for the three months ended December 31, 2019 and 2018, respectively.
The Company’s service revenues amounted to $879,000 and $813,000 for the nine months ended December 31, 2019 and 2018, respectively.
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef